Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02414659
Other study ID # 003
Secondary ID
Status Completed
Phase N/A
First received April 5, 2015
Last updated June 22, 2015
Start date March 2015
Est. completion date May 2015

Study information

Verified date June 2015
Source Ankara University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Observational

Clinical Trial Summary

Umbilical cord blood (UCB) collection and storage is a rapidly advancing field in hematology due to UCB's use for treatment of many hematological diseases, including but not limited to, Fanconi anemia, thalassemia, leukaemia and metabolic storage diseases. Primarily, there are two ways for UCB harvesting, first in-utero collection and second ex-utero collection. Depending on the amount of UCB collected, in-utero harvesting practice prolongs the operative time of cesarean delivery and speculatively increases intraoperative blood loss. The aim of this study is to determine UCB collection's effect on intraoperative bleeding in women undergoing elective cesarean delivery.


Description:

Elective cesarean deliveries that occurred in Ankara University Department of Obstetrics and Gynecology between March 2014 and February 2015 were enrolled in the study. Deliveries were divided into two groups depending whether cord blood was collected or not. All cesarean deliveries were performed via Joel-Cohen incisions. Cord blood was harvested in-utero, i.e. while leaving the placenta inside the uterus, after delivery of the baby and clamping of the cord. After UCB collection, placenta was delivered and hysterotomy site was repaired in one layer with continuous locking. Postpartum hemorrhage prophylaxis were performed with one dose of 0.2 mg methylergonovine maleate. Postoperatively patients were hydrated with 100cc per hour infusion of isotonic liquids and bloods were drawn at eight hours postoperatively for control blood counts. Amount of blood loss was estimated by subtracting preoperative hemoglobin and hematocrit levels from postoperative hemoglobin and hematocrit. Delta hemoglobin and hematocrit levels were compared between two groups. Correlation between amount of UCB collected and blood loss was also analysed.

Patients without a preoperative blood count within 30 days prior to delivery were excluded from the study, along with patients with history of bleeding 30 days prior to delivery. Emergent cesarean deliveries, postpartum bleeding due to uterine atony, retained placenta, cesarean deliveries performed due to placental adhesion abnormalities (placenta previa, placenta accreta), patients on anticoagulation regimens (aspirin, low molecular weight heparin, heparin), patients with a post-operative haemoglobin level higher than pre-operative levels were all excluded from the study. Patients were selected at random from birth register by two people who are blind to pre and post-operative blood count results.


Recruitment information / eligibility

Status Completed
Enrollment 399
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Elective cesarean deliveries

- Women with a blood count results maximum 30 days prior to delivery

Exclusion Criteria:

- Emergent cesarean deliveries

- Cesarean deliveries due to placental adhesion abnormalities or placenta previa

- Patients on anticoagulation regimens

- Postpartum bleeding due to uterine atony, retained placenta

- Patients with a history of bleeding 30 days prior to delivery

Study Design

Observational Model: Case Control, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Procedure:
Umbilical cord blood collection, in-utero
Umbilical cord blood was collected during cesarean, after delivery of the baby and after clamping of the cord. Blood was collected into a standard blood donation bag with (Capacity: 450 mL) a 16 G venipuncture needle. Needle was left in place after umbilical vein is collapsed and no more blood flow happens spontaneously.

Locations

Country Name City State
Turkey Ankara University Faculty of Medicine, Department of Obstetrics and Gynecology Ankara

Sponsors (2)

Lead Sponsor Collaborator
Ankara University Middle East Technical University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative hemoglobin levels Bloods were drawn from patients during their 8th postoperative hour for control blood counts. 8 hours No
Primary Postoperative hematocrit levels Bloods were drawn from patients during their 8th postoperative hour for control blood counts. 8 hours No
See also
  Status Clinical Trial Phase
Recruiting NCT03672071 - Effects of Norepinephrine-ephedrine Combination on Maternal Hemodynamics N/A
Completed NCT01216098 - Impact of Doula Support on Childbirth Outcomes for Women Undergoing a Vaginal Birth After Cesarean (VBAC) N/A
Recruiting NCT03433976 - Prilocaine or Bupivacaine for Spinal Anesthesiain Pregnant Phase 2
Completed NCT00922142 - Cesarean Postoperative Pain Satisfaction N/A
Completed NCT00501033 - A Prospective Comparative Study of Induction of Labor With a Cervical Ripening Double Balloon vs Foley Catheter N/A
Not yet recruiting NCT03719625 - Norepinephrine Versus Ephedrin for Prevention of Post Spinal Anesthesia in Cesarean Section Phase 4
Recruiting NCT05133271 - Prediction of Maternal Arterial Hypotension After Spinal Anesthesia by Passive Leg Raise Test. N/A
Completed NCT03147781 - Auricular Therapy for Postpartum Lactation N/A